Caroline Robert
MD, PhD
Head of Dermatology
👥Biography 个人简介
Caroline Robert co-led KEYNOTE-054 (EORTC 1325) establishing adjuvant pembrolizumab as standard for resected stage III melanoma with sustained recurrence-free and distant metastasis-free survival benefit. Her Gustave Roussy group shaped melanoma IO development across metastatic and adjuvant settings. She continues research on long-term outcomes and biomarkers.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Caroline Robert 的研究动态
Follow Caroline Robert's research updates
留下邮箱，当我们发布与 Caroline Robert（Gustave Roussy）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment